- POSITIVE
Annual Revenue Neochem Bio Solutions Mar-2026 Annual Revenue is Rs 113 Cr which is growth of 31.6% YoY.
- POSITIVE
Annual Net Profit Neochem Bio Solutions Mar-2026 Annual Net Profit is Rs 12 Cr which is growth of 61.6% YoY.
Neochem Bio Solutions was incorporated on March 6, 1978. The company is a four-decade-old specialty performance chemical manufacturer offering 350+ customized formulations across polymers, surfactants, silicones, and bio-based esters. Its products serve diverse industries and are backed by certifications such as ISO 9001:2015, ISO 14001, ISO 45001, ZDHC Level 3, and GOTS 7.0
| Bidding Dates |
|---|
| 02 Dec 2025 - 04 Dec 2025 |
| Subscription |
|---|
| 14.49x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹223,200 | 2 | 2 | 1200 | 4.6 M | ₹93 - ₹98 | 66.7 % | ₹426.8 M - ₹449.7 M | RHP DOC |
Neochem Bio Solutions IPO SUBSCRIPTION STATUS
04 Dec '25Total14.49x
Retail Individual Investor12.5x
HNI (NII) Investors28.59x
Qualified Institutional Buyers11.65x
Neochem Bio Solutions IPO overall subscription rate was 14.49 times the total available shares
Neochem Bio Solutions IPO retail subscription rate was 12.5 times in the retail segment
Neochem Bio Solutions IPO non-institutional investor subscription rate was 28.59 times in the non-institutional investor category
Neochem Bio Solutions IPO Qualified Institutional Bidder subscription rate was 11.65 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
04 Dec 2025 (Day 3) | 12.5x | 28.59x | 11.65x |
03 Dec 2025 (Day 2) | 1.33x | 3.14x | 0.65x |
02 Dec 2025 (Day 1) | 0.63x | 1.46x | 0.53x |
Neochem Bio Solutions FINANCIALS
| Period | Revenue from Operations (Rs in crore) | Net Profit (Rs in crore) | Cash Flow from Operations (Rs in crore) | Free Cash Flow (Rs in crore) | Margins |
| H1FY26 | 45.8 | 5.5 | -7.7 | -10.0 | 18.8% |
| FY25 | 84.2 | 7.8 | 2.6 | 1.5 | 15.6% |
| FY24 | 61.1 | 1.8 | 2.0 | -3.4 | 9.8% |
| FY23 | 48.2 | 1.1 | -0.7 | -4.1 | 8.8% |
Neochem Bio Solutions IPO SUBSCRIPTION STATUS DETAILS
Neochem Bio Solutions had 4.6 M shares on offer
Neochem Bio Solutions IPO offer price was in the range ₹93 - ₹98
Neochem Bio Solutions IPO minimum Investment was ₹223200
Neochem Bio Solutions IPO issue size was ₹ 426.8 M - ₹ 449.7 M
Neochem Bio Solutions had a minimum lot size of 1200 Shares per application
Neochem Bio Solutions NUMBER OF SHARES ON OFFER
Total4.6 M
Fresh Issue4.6 M
Offer for Sale0
Post Issue Promoter Holding %66.7 %
Neochem Bio Solutions IPO IMPORTANT DATES
| Issue Open Date | 02 Dec 2025 |
| Issue close Date | 04 Dec 2025 |
| Allotment Date | 05 Dec 2025 |
| Refund Date | 08 Dec 2025 |
| Demat Account Credit Date | 08 Dec 2025 |
| Listing Date | 09 Dec 2025 |
| Listing on Exchange(s) | NSE |
| Neochem Bio Solutions Allotment Status | Exchange/ Registrar |
Neochem Bio Solutions IPO subscription opened on 02 Dec 2025, and closed on 04 Dec 2025
IPO allotment for Neochem Bio Solutions was finalized on Friday, 05 Dec 2025
IPO listing for Neochem Bio Solutions was on NSE on Tuesday, 09 Dec 2025
Neochem Bio Solutions IPO LISTING GAINS
| Issue Price (adjusted) | 98.0 |
| Listing Open Price | 108.0 |
| Listing Close Price | 111.8 |
| Listing Gain% | 10.2% |
| Current Gain% | 3.1% |
Neochem Bio Solutions Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neochem Bio Solutions Ltd. | 101 | 172.9 | 14.4 | 0.2 | 1.5 | 15.2 | 10.3 | 113.4 | 31.6 | 12 | 61.6 | 7 | 61.6 |
| Pidilite Industries Ltd. | 1464 | 149114.3 | 56.3 | 2.6 | 9.7 | 22.6 | 15.9 | 14867 | 11.1 | 2448.9 | 17.9 | 26 | 21.4 |
| SRF Ltd. | 2486.2 | 73697.1 | 34.1 | 0.7 | 4.3 | 13.1 | 7.6 | 15893.6 | 7.2 | 1835.2 | 46.7 | 72.9 | 51.1 |
| Gujarat Fluorochemicals Ltd. | 4341.5 | 47691.4 | 77.5 | -68.9 | 9 | 7.3 | 4.8 | 5126.3 | 5.6 | 577.4 | 5.7 | 56 | -1.1 |
| Himadri Speciality Chemical Ltd. | 665.2 | 33561.8 | 42 | 1.4 | 6.7 | 16 | 11.9 | 4832 | 3.6 | 751.3 | 35.2 | 15.8 | 30 |
| Aether Industries Ltd. | 1670 | 22165.5 | 94.2 | 2.8 | 18.1 | 8.9 | 6.8 | 1181.1 | 34.2 | 219.5 | 38.5 | 17.7 | 34 |
Annual
Balance Sheet
Ratios
Cash Flow
Neochem Bio Solutions annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 |
|---|---|---|---|---|---|---|---|
32.5% | 113.4 | 86.2 | 62 | 48.8 | 48.7 | ||
Operating Exp. Ann. | 27.5% | 90.9 | 71.4 | 55 | 43.9 | 45.1 | |
Operating Profit Ann. | 66.6% | 19.9 | 12.8 | 6.1 | 4.3 | 3.5 | |
OPM Ann. % | 25.7% | 17.51% | 14.86% | 9.86% | 8.81% | 7.21% | |
26.5% | 95.6 | 76.2 | 59.2 | 47.2 | 47.4 | ||
EBITDA Ann. | 66.5% | 22.6 | 14.8 | 7 | 4.9 | 3.6 | |
EBITDA Ann. margin % | 25.6% | 19.89% | 17.16% | 11.25% | 10.04% | 7.40% | |
Interest Ann. | 18.6% | 3.5 | 3.5 | 3 | 2.1 | 1.3 | |
Depr. | 0% | 1.2 | 1.3 | 1.2 | 1.2 | 1 | |
PBT Ann. | 120.7% | 17.2 | 10 | 2.8 | 1.6 | 1.3 | |
Tax Ann. | 118.3% | 5.2 | 2.5 | 0.9 | 0.5 | 0.3 | |
121.8% | 12 | 7.4 | 1.9 | 1.1 | 1 | ||
Net Profit Ann. | 121.8% | 12 | 7.4 | 1.9 | 1.1 | 1 | |
NPM Ann. % | 66.3% | 10.86% | 8.83% | 3.15% | 2.36% | 1.99% | |
EPS Adj. latest Ann. | 115.4% | 7 | 4.4 | 1.1 | 0.7 | 0.6 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
31.6%
2Y CAGR
35.2%
3Y CAGR
32.5%
Net Profit Ann.
1Y CHG
62.2%
2Y CAGR
151.3%
3Y CAGR
121.8%
Operating Exp. Ann.
1Y CHG
27.3%
2Y CAGR
28.6%
3Y CAGR
27.5%
Neochem Bio Solutions INFORMATION ON IPO ISSUE
About Neochem Bio Solutions
Neochem Bio Solutions was incorporated on March 6, 1978. The company is a four-decade-old specialty performance chemical manufacturer offering 350+ customized formulations across polymers, surfactants, silicones, and bio-based esters. Its products serve diverse industries and are backed by certifications such as ISO 9001:2015, ISO 14001, ISO 45001, ZDHC Level 3, and GOTS 7.0
Object of the Issue
- Funding the long-term working capital requirements of the company
- Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by the company
- General corporate purposes
Neochem Bio Solutions - PROMOTERS
| Name |
|---|
| Swapnil Rameshbhai Makati |
| Hemangini Swapnil Dathia |
Neochem Bio Solutions - MANAGEMENT & LEADERSHIP
| Name | Designation |
|---|---|
| Dinesh Chopra | Chairperson & Non- Executive Director |
| Swapnil Rameshbhai Makati | Managing Director |
| Hemangini Swapnil Dathia | Whole-Time Director |
| Rajasekaran Guha | Non- Executive Director |
| Falgunbhai Prajapati | Independent Director |
| Shail Jayesh Shah | Independent Director |
Neochem Bio Solutions Book Running Lead Manager
Vivro Financial Services Private Limited
investors@vivro.net
Neochem Bio Solutions Registrar to the issue
MUFG Intime India Private Limited
neochem.smeipo@in.mpms.mufg.com
Neochem Bio Solutions Strengths
Integrated & flexible operations
The company operates an integrated manufacturing facility in Moraiya, Ahmedabad, enabling in-house production of key intermediates and proprietary formulations across multiple chemistries. This structure ensures better control over quality, cost efficiency, and reliable supply for specialty performance chemicals
Strength
Diversified across industries
With over four decades of experience and a technically skilled team, the company has strong application and process expertise across industries such as textiles, home and personal care, cleaning, construction, paints, water treatment, and more. Its portfolio of 350+ customized formulations across polymers, surfactants, silicones, esters, and bio-based solutions enables it to meet diverse functional, regulatory, and quality requirements
Strength
R&D capabilities
The company’s in-house R&D facility in Moraiya, Ahmedabad, develops environmentally sustainable, customer-specific chemical solutions through advanced testing and formulation capabilities. Its focus on process optimization and bio-based innovation has led to products like plant-derived softeners, phosphate-free agents, clay-based scouring solutions, and sustainable surfactants that reduce carbon footprint and enhance product lifecycle performance
Strength
Neochem Bio Solutions Risks
Quality standards
The company must meet strict quality standards for its specialty performance chemicals, and any failure to comply could lead to loss of customers and negatively impact operations. Its products serve as key raw materials across industries such as textiles, home and personal care, industrial cleaning, water treatment, paints, paper, construction, rubber, and pigments
Risk
Accident risks
The company operates in a hazardous industry where accidents, fires, or mishaps at its manufacturing facilities could lead to injury claims and loss of property, inventory, and raw materials. Despite having public liability insurance, there is no assurance that claims will always be recoverable, which may require the company to bear compensation costs directly
Risk
Competition
The company operates in a highly competitive industry, facing pricing pressure from domestic and international manufacturers with stronger capabilities and new entrants offering advanced or lower-cost products. Such competition may reduce its pricing flexibility, strain profit margins, and adversely affect business growth and operational results
Risk
IPO FAQs
The promoters of the company are Swapnil Rameshbhai Makati and Hemangini Swapnil Dathia.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 93.0 - 98.0.
The IPO application opens on Dec 02, 2025 and closes on Dec 04, 2025.
The minimum lot size for the IPO is 2400. The maximum lot size for the IPO is 2400.
For all category investors, the minimum application amount for this IPO is Rs. 223,200.0, the maximum value for this IPO is Rs 235,200.0.
This IPO will be allotted on Dec 05, 2025.
The refund will be credited to your account on Dec 08, 2025.
The allotted shares will be credited to your demat on Dec 08, 2025.
Neochem Bio Solutions Ltd.’s shares listed on the stock exchanges on Dec 09, 2025.